Basics |
bioAffinity Technologies, Inc.
|
IPO Date: |
September 1, 2022 |
Sector: |
Healthcare |
Industry: |
Diagnostics and Research |
Market Cap: |
$12.96M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.09 | 5.16%
|
Avg Daily Range (30 D): |
$0.21 | 7.16%
|
Avg Daily Range (90 D): |
$0.11 | 5.85%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.7M |
Avg Daily Volume (30 D): |
10.99M |
Avg Daily Volume (90 D): |
6.02M |
Trade Size |
Avg Trade Size (Sh.): |
298 |
Avg Trade Size (Sh.) (30 D): |
220 |
Avg Trade Size (Sh.) (90 D): |
296 |
Institutional Trades |
Total Inst.Trades: |
13 |
Avg Inst. Trade: |
$1.29M |
Avg Inst. Trade (30 D): |
$1.27M |
Avg Inst. Trade (90 D): |
$1.27M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-.57
|
$-.17
|
$-.16
|
Diluted EPS
|
$-.57
|
$-.17
|
$-.16
|
Revenue
|
$ 7.68M
|
$ 1.27M
|
$ 1.85M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -11.69M
|
$ -4.06M
|
$ -2.66M
|
Operating Income / Loss
|
$ -10.06M
|
$ -2.52M
|
$ -2.63M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ .36M
|
$ -.66M
|
PE Ratio
|
|
|
|
Splits |
Sep 19, 2025:
1:30
|
|
|
|